Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1164-1170

  Kastenbauer, S ^a   Koedel, U ^a   Pfister, Hans Walter ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; EVANS BLUE; PEROXYNITRITE; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID CYTOLOGY; CONTROLLED STUDY; IMMUNOREACTIVITY; INTRACRANIAL PRESSURE; LEUKOCYTE COUNT; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; FREE RADICAL SCAVENGERS; INFLAMMATION; INTRACRANIAL PRESSURE; LEUKOCYTES; MALE; MENINGITIS, PNEUMOCOCCAL; NITRATES; OXIDANTS; RATS; RATS, WISTAR; SUBARACHNOID SPACE; TYROSINE; URIC ACID;

EID: 0033375029     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315048     Document Type: Article

References (45)

1. Quagliarello VJ, Scheld WM, New perspectives on bacterial meningitis. Clin Infect Dis 1993;17:603-8.
2. Koedel U, Pfister HW. Protective effect of the antioxidant N-acetyl-L-cysteine in pneumococcal meningitis in the rat. Neurosci Lett 1997;225:33-6.
3. Koedel U, Bernatowicz A, Paul R, Frei K, Fontana A, Pfister HW. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann Neurol 1995;37:313-23.
4. Buster BL, Weintrob AC, Townsend GC, Scheld WM. Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect Immun 1995;63:3835-9.
5. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
6. Beckman JS, Koppenol WH. Nitric oxide, Superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-37.
7. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994;263:687-9.
8. Bagasra O, Michaels FH, Zheng YM, et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995;92:12041-5.
9. Coeroli L, Renolleau S, Arnaud S, et al. Nitric oxide production and perivascular tyrosine nitration following focal ischemia in neonatal rat. J Neurochem 1998;70:2516-25.
10. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RHJ. Increased 3-nitrotyrosine in both Sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 1997;42:644-54.
11. Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, Beckman JS. Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med 1997;25:812-9.
12. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995;151:1250-4.
13. Ye YZ, Strong M, Huang ZQ, Beckman JS. Antibodies that recognize nitrotyrosine. Methods Enzymol 1996;269:201-9.
14. Hooper DC, Bagasra O, Marini JC, et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997;94:2528-33.
15. Pfister HW, Frei K, Ottnad B, Koedel U, Tomasz A, Fontana A. Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis. J Exp Med 1992;176:265-8.
16. Paul R, Lorenzl S, Koedel U, et al. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 1998;44:592-600.
17. Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M. Quantítative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood How Metab 1988;8:282-4.
18. Ischiropoulos H, Beers MF, Ohnishi ST, Fisher D, Garner SE, Thom SR. Nitric oxide production and perivascular nitration in brain after carbon monoxide poisoning in the rat. J Clin Invest 1996;97:2260-7.
19. Chang LT, Neill AL, Hunt NH. Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am J Pathol 1992;140:1121-30.
20. Koedel U, Pfister H-W. Oxidative stress in bacterial meningitis. Brain Pathol 1999;9:57-67.
21. Leib SL, Kim YS, Chow LL, Sheldon RA, Tauber MG. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest 1996;98:2632-9.
22. Dirnagl U, Koedel U, Pfister HW, Villringer A, Schleinkofer L, Einhaupl KM. Detection of brain free oxygen radical generated photons in vivo: preliminary results. Adv Exp Med Biol 1993;333:203-12.
23. Pfister HW, Koedel U, Haberl RL. et al. Microvascular changes during the early phase of experimental bacterial meningitis. J Cereb Blood Flow Metab 1990;10:914-22.
24. McKnight AA, Keyes WG, Hudak ML, Jones MDJ. Oxygen free radicals and the cerebral arteriolar response to group B streptococci. Pediatr Res 1992;31:640-4.
25. Berkowitz I, Traystman R. Oxygen radical scavengers prevent impairment of microvascular autoregulation in Haemophilus influenzae type b meningitis in rats. FASEB J 1993;7:A530.
26. Hubert RL, Anneser F, Koedel U, Pfister HW. Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis? Neurol Res 1994;16:108-12.
27. van Furth AM, Seijmonsbergen EM, Groeneveld PH, van Furth R, Langermans JA. Levels of nitric oxide correlate with high levels of tumor necrosis factor alpha in cerebrospinal fluid samples from children with bacterial meningitis. Clin Infect Dis 1996;22:876-8.
28. Visser JJ, Scholten RJ, Hockman K. Nitric oxide synthesis in meningococcal meningitis. Ann Intern Med 1994;120:345-6.
29. Leib SL, Kim YS, Black SM, Tureen JH, Tauber MG. Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J Infect Dis 1998;177:692-700.
30. Beckmann JS, Ye YZ, Anderson PG. et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry Biol Chem Hoppe Seyler 1994;375:81-8.
31. van der Veen RC, Hinton DR. Incardonna F, Hofman FM. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol 1997;77:1-7.
32. Bidmon HJ, Wu J, Godecke A, Schleicher A, Mayer B, Zilles K. Nitric oxide synthase-expressing neurons are area-specifically distributed within the cerebral cortex of the rat. Neuroscience 1997;81:321-30.
33. Malawista SE, Montgomery RR, van-Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts: a new microbicidal pathway for polymorphonuclear leukocytes. J Clin Invest 1992;90:631-6.
34. Kim YS, Tauber MG. Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production. Infect Immun 1996;64:3148-53.
35. Bernatowicz A, Koedel U, Frei K, Fontana A, Pfister HW. Production of nitrite by primary rat astrocytes in response to pneumococci. J Neuroimmunol 1995;60:53-61.
36. Koedel U, Pfister HW. Superoxide production by primary rat cerebral endothelial cells in response to pneumococci. J Neuroimmunol 1999;96:190-200.
37. Whiteman M, Halliwell B. Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid: a comparison with other biological antioxidants. Free Radic Res 1996;25:275-83.
38. Hooper DC, Spitsin S, Kean RB. et al. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1998;95:675-80.
39. Bolanos JP, Almeida A, Stewart V, et al. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 1997;68:2227-40.
40. Maeda H, Okamoto T, Akaike T. Human matrix metalloprotease activation by insults of becterial infection involving proteases and free radicals. Biol Chem 1998;379:193-200.
41. Frears ER, Zhang Z, Blake DR, O'Connell JP, Winyard PC. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett 1996;381:21-4.
42. Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock; importance of the activation of poly(ADP-ribose) synthetic by peroxynitrite. J Clin Invest 1997;100:723-35.
43. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;41:1819-28.
44. Lorenzl S, Koedel D, Frei K, Bernatowicz A, Fontana A, Pfister HW. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis. J Infect Dis 1995;172:113-8
45. Koedel U, Paul R, Sporer B, Pfister H-W. Beneficial effects of 3-aminobenzamide (3-AB), an inhibitor of the poly(ADP-ribose) polymerase (PARP), in experimental pneumococcal meningitis [abstract 775.3]. Soc Neurosci Abstr 1998;24:1956.